Formulation Development of a Multidose Lyophilized Measles-Rubella (MR) Vaccine Candidate for Local Manufacturing in Africa: Lab-Scale Results and Lessons-Learned for Future Technology Transfer (dataset)

Protect her future: Lessons learned from a school and community engagement initiative for HPV vaccine awareness in Lilongwe, Malawi

Formulation development of recombinant adenovirus-based vaccine for Newcastle disease

Kamen, Amine (Supervisor) Newcastle Disease has been causing much economic loss and food security is

Introduction of rubella-containing-vaccine to Madagascar: implications for roll-out and local elimination

International audience Few countries in Africa currently include rubella-containing v

Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]

Abstract Background New strategies to increase measles and rube

The Epidemiology of Rubella in Lesotho before the Introduction of a Rubella Containing Vaccine: A Review of Measles Case-based Surveillance, 2012-2016

Aim: The aim of the study was to determine the burden and epidemiology of rubella infection in Lesot

Intranasally Delivered Adenoviral Vector Protects Chickens against Newcastle Disease Virus: Vaccine Manufacturing and Stability Assessments for Liquid and Lyophilized Formulations

Newcastle Disease (ND) remains a critical disease affecting poultry in sub-Saharan Africa. In some c